Literature DB >> 2564656

Pseudonasolacrimal duct obstruction caused by nasal allergy.

R F Sanke1.   

Abstract

While mechanical obstruction of the nasolacrimal duct is the most common cause of acquired unilateral epiphora, it is not the only one. Of the 94 patients evaluated with this symptom, 22 cases (23%) were caused by primary nasal changes in the form of nasal allergy. Many of the characteristic findings of mechanical obstruction were present. Several patients had previous nasolacrimal duct surgery, which failed to eliminate the epiphora. Nasal allergy was not initially considered either by previous examiners or the patients themselves, because of the absence of typical allergic symptoms. All of these patients, however, obtained relief from their unilateral tearing with treatment directed toward the nasal pathology only. Oral sympathomimetics and antihistamines were the most effective. Two patients improved with primary nasal surgery.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564656

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  4 in total

Review 1.  Allergic conjunctivitis and the impact of allergic rhinitis.

Authors:  Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

2.  Effect of topical steroids on recently developed incomplete nasolacrimal duct obstruction: optical coherence tomography study.

Authors:  Min Kyu Yang; Namju Kim; Ho-Kyung Choung; Sang In Khwarg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-24       Impact factor: 3.117

3.  Predisposing factors for primary acquired nasolacrimal duct obstruction.

Authors:  Kazuyoshi Ohtomo; Takashi Ueta; Taku Toyama; Miyuki Nagahara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-28       Impact factor: 3.117

Review 4.  Relationship between allergic rhinitis and allergic conjunctivitis (allergic rhinoconjunctivitis) - review.

Authors:  Andreea Iordache; Mădălina Boruga; Ovidiu Mușat; Daniel Alexandru Jipa; Călin Petru Tătaru; Gabriela Cornelia Mușat
Journal:  Rom J Ophthalmol       Date:  2022 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.